These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3802533)

  • 1. Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases.
    van Zanten AP; Twijnstra A; Hart AA; Ongerboer de Visser BW
    Clin Chim Acta; 1986 Dec; 161(3):259-68. PubMed ID: 3802533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases.
    van Zanten AP; Twijnstra A; van Benthem V; Hart AA; Ongerboer de Visser BW
    Clin Chim Acta; 1985 Apr; 147(2):127-34. PubMed ID: 3987058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.
    Twijnstra A; van Zanten AP; Hart AA; Ongerboer de Visser BW
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):313-20. PubMed ID: 3559613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDH isoenzymes in cerebrospinal fluid in various brain tumours.
    Lampl Y; Paniri Y; Eshel Y; Sarova-Pinhas I
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):697-9. PubMed ID: 2213048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
    Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
    Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in CSF-LDH isoenzymes in cerebrospinal tumors].
    Yuan XH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Apr; 20(2):116-8. PubMed ID: 3497784
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid biochemical markers of central nervous system metastases.
    Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
    Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid lactic acid dehydrogenase activity. Levels in untreated and partially antibiotic-treated meningitis.
    Feldman WE
    Am J Dis Child; 1975 Jan; 129(1):77-80. PubMed ID: 1168986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change.
    Royds JA; Timperley WR; Taylor CB
    J Neurol Neurosurg Psychiatry; 1981 Dec; 44(12):1129-35. PubMed ID: 7334408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer.
    Dearnaley DP; Patel S; Powles TJ; Coombes RC
    Oncodev Biol Med; 1981; 2(4):305-11. PubMed ID: 7301610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic significance of lactate concentration in CSF in patients with meningitis (author's transl)].
    Kleine TO; Baerlocher K; Niederer V; Keller H; Reutter F; Tritschler W; Bablok W
    Dtsch Med Wochenschr; 1979 Apr; 104(15):553-7. PubMed ID: 436627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
    Bach F; Soletormos G; Dombernowsky P
    J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactic dehydrogenase in cerebrospinal fluid may differentiate between structural and non-structural central nervous system lesions in patients with diminished levels of consciousness.
    Vázquez JA; Adducci Mdel C; Godoy Monzón D; Iserson KV
    J Emerg Med; 2009 Jul; 37(1):93-7. PubMed ID: 18993016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical picture of central nervous system lesions in hematosarcoma].
    Konchakova MI; Kruglova GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):329-33. PubMed ID: 6994419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.
    Twijnstra A; van Zanten AP; Nooyen WJ; Ongerboer de Visser BW
    J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1246-50. PubMed ID: 3540216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid bombesin and calcitonin in patients with central nervous system metastases from small-cell lung cancer.
    Pedersen AG; Becker KL; Bach F; Snider RH; Gazdar AF; Sorensen PS; Bunn PA; Hansen HH
    J Clin Oncol; 1986 Nov; 4(11):1620-7. PubMed ID: 3021922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic changes in the cerebrospinal fluid as indices of pathological change.
    Paşaoğlu A; Paşaoğlu H
    Acta Neurochir (Wien); 1989; 97(1-2):71-6. PubMed ID: 2718797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid biochemical markers in central nervous system tumors: a review.
    Wasserstrom WR; Schwartz MK; Fleisher M; Posner JB
    Ann Clin Lab Sci; 1981; 11(3):239-51. PubMed ID: 6166240
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid and metastasis of transitional cell carcinoma of the bladder.
    Hust MH; Pfitzer P
    Acta Cytol; 1982; 26(2):217-23. PubMed ID: 6952725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.